Prognostic variables and nomograms for renal cell carcinoma. 2011

Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
Department of Urology, Loyola University Stritch School of Medicine, Maywood, Illinois 60153, USA. rflanig@lumc.edu

The term renal cell carcinoma (RCC) is used to describe a heterogeneous group of tumors that vary histologically, genetically and molecularly. Extensive research has been conducted to identify characteristics that predict outcomes among patients with RCC. In addition to histological subtype these include tumor size, patient age, mode of presentation and various hematological indices, among others. Several groups have incorporated these clinical and pathological features into nomograms which help the clinician better define individual patient prognosis and direct the optimum therapeutic approach. In the present article we review these prognostic variables and nomograms for RCC.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D049451 Nomograms Graphical representation of a statistical model containing scales for calculating the prognostic weight of a value for each individual variable. Nomograms are instruments that can be used to predict outcomes using specific clinical parameters. They use ALGORITHMS that incorporate several variables to calculate the predicted probability that a patient will achieve a particular clinical endpoint. Partin Nomograms,Partin Tables,Nomogram,Nomogram, Partin,Nomograms, Partin,Partin Nomogram,Partin Table,Table, Partin,Tables, Partin

Related Publications

Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
March 2005, BJU international,
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
January 2021, Journal of oncology,
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
October 2022, Translational andrology and urology,
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
January 2024, Clinics (Sao Paulo, Brazil),
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
January 2021, BioMed research international,
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
September 2006, Journal of surgical oncology,
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
December 2006, BJU international,
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
October 2022, Translational andrology and urology,
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
August 2008, Cancer treatment reviews,
Robert C Flanigan, and Anthony J Polcari, and Cory M Hugen
June 1980, European journal of cancer,
Copied contents to your clipboard!